Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-04

FDA Approved: SELEGILINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for Selegiline Hydrochloride from Chartwell RX, LLC, enabling the generic product's approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SELEGILINE HYDROCHLORIDE (Selegiline hydrochloride)

Snippet

SUPPL AP for SELEGILINE HYDROCHLORIDE (SELEGILINE HYDROCHLORIDE)